Evidence map›Paper›PMID 40690185›Full record

ArticleJournal of neuro-oncology2025

Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort study.

Tareq M Haedenkamp, Linda Götz, Tananeh Ansafi, Michael Gerken, Monika Klinkhammer-Schalke, Anna Fischl, Markus J Riemenschneider, Julia Maurer, Martin Proescholdt, Oliver Kölbl and 4 more

Abstract read
In one paragraph

Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Food group intake and chemotherapy-induced toxicity: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tareq M HaedenkampDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Linda GötzDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Tananeh AnsafiDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Michael GerkenCenter for Quality Assurance and Health Services Research, University of Regensburg, Regensburg, Germany.
Monika Klinkhammer-SchalkeCenter for Quality Assurance and Health Services Research, University of Regensburg, Regensburg, Germany.
Anna FischlDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Markus J RiemenschneiderDepartment of Neuropathology, Regensburg University Hospital, Regensburg, Germany.
Julia MaurerCancer Registry, University Cancer Center Regensburg, Regensburg University Hospital, Regensburg, Germany.
Martin ProescholdtDepartment of Neurosurgery, Regensburg University Hospital, Regensburg, Germany.
Oliver KölblDepartment for Radiotherapy, Regensburg University Hospital, Regensburg, Germany.
Nils Ole SchmidtDepartment of Neurosurgery, Regensburg University Hospital, Regensburg, Germany.
Ralf LinkerDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Elisabeth BumesDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.
Peter HauDepartment of Neurology and Wilhelm Sander-NeuroOncology Unit, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. peter.hau@ukr.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGlioblastoma is the most prevalent primary malignant brain tumour in adults and bears poor survival. Data on associations of nutrition with outcome parameters are scarce. Our aim was to investigate whether dietary habits influence chemotherapy-related toxicity and overall survival in patients with glioblastoma.

methodsIn this retrospective cohort study, we included glioblastoma patients who received treatment between January 2010 and December 2019. We used a 35-item food frequency questionnaire to calculate a dietary score based on Mediterranean-like diet recommendations. We analysed relationships between nutrition score, side effects and survival using chi square tests, binary logistic regression, Kaplan-Meier and multivariable Cox regression analyses.

resultsFrom an initial population of 1,448 patients, a homogenous cohort of 128 glioblastoma cases were included in our final analysis. Patients with a higher score than the median, tending to a more Mediterranean-like diet, showed more infections (13.8% vs. 3.2%, p = 0.031) and a trend for more myelodepression (32.3% vs. 17.5%, p = 0.052). A higher score was predictive for infections (OR = 12.33, 95% CI: 1.36-111.98; p = 0.026). Median survival was worse in the higher score group (16.6 vs. 19.4 months, p = 0.004), confirmed by multivariable cox regression analysis (HR 1.60, 95% CI 1.04–2.46; p = 0.034).

conclusionWe identified associations between dietary patterns and chemotherapy-related toxicity as well as outcome. Our findings underscore the potential impact of nutrition on cancer treatment outcomes. Further research is needed to validate these results and to address possible underlying mechanisms.

Indexed as

Brain NeoplasmsDiet, MediterraneanFeeding BehaviorGlioblastomaAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesSurvival RateDietFood frequency questionnaireGlioblastomaSurvivalTherapy-related toxicity

Identifiers

PMID40690185
PMCPMC12367922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.